reviewDiabetes & Metabolism JournalJan 1, 2012GOLD OA

Anti-Obesity Drugs: A Review about Their Effects and Safety

Kangbuk Samsung Hospital · Sungkyunkwan University

PubMed
Indexed incrossrefdoajpubmed

Abstract

The current recommendations for the treatment of obese people include increased physical activity and reduced calories intake. When the behavioral approach is not sufficient, a pharmacologic treatment is recommended. In past years, numerous drugs have been approved for the treatment of obesity; however, most of them have been withdrawn from the market because of their adverse effects. In fact, amphetamine, rimonabant and sibutramine licenses have been withdrawn due to an increased risk of psychiatric disorders and non-fatal myocardial infarction or stroke. Even if orlistat is not as effective as other drugs in reducing body weight, orlistat is presently the only available choice for the treatment of obesity…

Citation impact

587
total citations
FWCI
26.95
Percentile
100%
References
53
Citations per year

Authors

2

Topics & keywords

Keywords
  • Orlistat
  • Sibutramine
  • Medicine
  • Rimonabant
  • Obesity
  • Phentermine
  • Adverse effect
  • Diabetes mellitus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.